VPMV
CNST

Venrock Partners Management V’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Venrock Partners Management V’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$3.97M Buy
+132,026
New +$4.76M 3.94% 2

Other funds holding CNST

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMV
Venrock Management V Palo Alto, California $719M AUM
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Venrock Partners Management V's CNST Position: Q2 2020 in Review

Venrock Partners Management V opened a new position in Constellation Pharmaceuticals, Inc. (CNST) in Q2 2020: 132,026 shares worth $3.97M. The stake represents 3.94% of the portfolio and ranks #2 among its holdings.

132 funds tracked by Wall St. Rank hold CNST as of Q2 2020.

  • Venrock Partners Management V held 132,026 shares of Constellation Pharmaceuticals, Inc. worth $3.97M as of Q2 2020.
  • Constellation Pharmaceuticals, Inc. was a new Venrock Partners Management V position in Q2 2020.
  • Constellation Pharmaceuticals, Inc. made up 3.94% of Venrock Partners Management V's portfolio in Q2 2020, its #2 holding.
  • 132 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2020.

Based on Venrock Partners Management V's 13F filing for Q2 2020, filed 13 Aug 2020.